Abstract
The reaction of indoles with various aldehydes to give corresponding bis(3-indolyl)phenylmethanes in aqueous medium was catalyzed by 1-(benzenesulfonyl)-3-methyl-1H-imidazolium chlorides which were obtained by solvent-free approach. Excellent yields within short duration were achieved after optimizing the reaction conditions. The thermal properties of all 1-(benzenesulfonyl)-3-methyl-1H-imidazolium chlorides were studied using thermogravimetric analysis.
Keywords: Aldehydes, aqueous media, bis(3-indolyl)phenylmethanes, indoles, sulfonylimidazolium chlorides.
Letters in Organic Chemistry
Title:Efficient Green Synthesis of Bis(3-indolyl)phenylmethanes Catalyzed by 1- (Benzenesulfonyl)-3-methyl-1H-imidazolium Chlorides
Volume: 10 Issue: 10
Author(s): Gantigaiah Krishnamurthy and Kesturu Venkatarayappa Jagannath
Affiliation:
Keywords: Aldehydes, aqueous media, bis(3-indolyl)phenylmethanes, indoles, sulfonylimidazolium chlorides.
Abstract: The reaction of indoles with various aldehydes to give corresponding bis(3-indolyl)phenylmethanes in aqueous medium was catalyzed by 1-(benzenesulfonyl)-3-methyl-1H-imidazolium chlorides which were obtained by solvent-free approach. Excellent yields within short duration were achieved after optimizing the reaction conditions. The thermal properties of all 1-(benzenesulfonyl)-3-methyl-1H-imidazolium chlorides were studied using thermogravimetric analysis.
Export Options
About this article
Cite this article as:
Krishnamurthy Gantigaiah and Jagannath Venkatarayappa Kesturu, Efficient Green Synthesis of Bis(3-indolyl)phenylmethanes Catalyzed by 1- (Benzenesulfonyl)-3-methyl-1H-imidazolium Chlorides, Letters in Organic Chemistry 2013; 10 (10) . https://dx.doi.org/10.2174/157017861010131126121040
DOI https://dx.doi.org/10.2174/157017861010131126121040 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MicroRNAs in Breast Cancer: One More Turn in Regulation
Current Drug Targets Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
Current Medicinal Chemistry γ δ T Cell Modulation in Anticancer Treatment
Current Cancer Drug Targets Patent Selections
Recent Patents on DNA & Gene Sequences Targeting the Voltage-Dependent K+ Channels Kv1.3 and Kv1.5 as Tumor Biomarkers for Cancer Detection and Prevention
Current Medicinal Chemistry Clinically Relevant Genetic Variations in Drug Metabolizing Enzymes
Current Drug Metabolism Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery
Current Medicinal Chemistry The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Preface The Urokinase-type Plasminogen Activator System in Cancer and other Pathological Conditions: Introduction and Perspective [Hot Topic: The Urokinase-type Plasminogen Activator System in Cancer (Executive Editor : S. Rosenberg)].
Current Pharmaceutical Design Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases
Current Pharmaceutical Design Metabolomics: A Revolution for Novel Cancer Marker Identification
Combinatorial Chemistry & High Throughput Screening Bioinformatics Comparison of G Protein of Isfahan Virus with the Same Proteins of Two Other Closely Related Viruses of the Genus Vesiculovirus
Protein & Peptide Letters Role of Free Fatty Acid Receptor 2 (FFAR2) in the Regulation of Metabolic Homeostasis
Current Drug Targets MicroRNA-Mediated Cancer Metastasis Regulation via Heterotypic Signals in the Microenvironment
Current Pharmaceutical Biotechnology Vascular Disrupting Agents (VDA) in Oncology: Advancing Towards New Therapeutic Paradigms in the Clinic
Current Drug Targets Drugging Cell Cycle Kinases in Cancer Therapy
Current Drug Targets Strategies for Salt Reduction in Foods
Recent Patents on Food, Nutrition & Agriculture Cell Cycle Kinases in Osteosarcoma: Potential for Therapeutic Intervention
Current Pharmaceutical Design Jab1-siRNA Induces Cell Growth Inhibition and Cell Cycle Arrest in Gall Bladder Cancer Cells via Targeting Jab1 Signalosome
Anti-Cancer Agents in Medicinal Chemistry Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating Properties
Current Medicinal Chemistry